Is the Production of Embryos in Small‐Scale Farming an Economically Feasible Enterprise?

The present assay attempts to evaluate the feasibility of using embryo transfer in small community farmers by in vivo study and by modelling the results obtained. From the total of 59 donor cows, 62.7% responded to treatment, with a significant difference (p = 0.002) in the percentage of the response between breeds, being 90.5% (19/21) in Holstein and 47.4% (18/38) in Brahman. A total of 283 embryos were graded as transferable, while 141 as non‐transferable, without difference in the percentage of transferable embryo by breed (p = 0.18). The mean of transferable embryos graded as class I and II was not different between Holstein and Brahman (p = 0.96 and p = 0.92, respectively); besides, no differences were observed in the other grades (non‐transferable). The highest difference in costs, regardless of its quality by breed, was seen in the lower levels of probable fertility of the embryo transferred, even reaching several hundred dollars. When modelling the expected costs for embryo produced and transferred, values can reach nearly $2000.00 when the probable fertility is only 10%. However, when the probable fertility was 60%, embryo cost was close to $300.00. This technology seems to be viable on average or high‐scale systems, having a superovulatory response between 60 and 80% with 4–6 transferrable embryos. Yet, in small‐scale farming, due to the reduced number of donors and/or recipients, the costs surpass the economical feasibility of the technique.     

Effects of Feeding Different Dietary Crude Protein and Digestible Energy to Yili Mares during Late Lactation Stage on Growth Development and Blood Biochemical Parameters of Foals

In this paper, thirty Yili mares aged 11 to 12 years with weighing 410 kg ± 30 kg, parity of 4 to 5 in third lactation month were selected, and were randomly divided into six groups, each group with five repeats.Two factors quadratic regression orthogonal rotational combination design was adopted to evaluate the effects of feeding different dietary CP and DE to mares on growth development and blood biochemical parameters of foals.Daily DE and CP feeding levels of the 6 groups were 92 MJ/d and 1.20 kg/d, 125 MJ/d and 1.20 kg/d, 92 MJ/d and 1.55 kg/d, 107 MJ/d and 1.35 kg/d, 125 MJ/d and 1.44 kg/d, 115 MJ/d and 1.55 kg/d, respectively.The results showed that body weight, body height, chest circumference and cannon circumference of foals of four and five months were not significant affected by maternal protein and energy intake (P>0.05).As compared with ration contained high DE (125 MJ/d) and low CP (1.20 kg/d), feeding with ration contained moderate DE (107 MJ/d) and CP (1.35 kg/d) improved body length of foals of four and five months significantly (P<0.05).From the blood biochemical parameters, such as total protein, albumin, triglyceride, high-density lipoprotein cholesterol, low density lipoprotein cholesterol, urea nitrogen, creatinine, alanine aminotransferase, there were no significant differences among all groups (P>0.05).Mares fed with ration contained moderate DE (107 MJ/d) and CP (1.35 kg/d) obviously improved the aspartate aminotransferase and uric acid level.In summary, Yili mares during lactation late stage fed with 1.35 kg/d CP and 107 MJ/d DE daily could significantly improve body length development of foals, and foals nitrogen metabolism was altered by maternal dietary nutrition through increasing blood aspartate aminotransferase activity.     

扁穗雀麦种质资源形态和农艺性状变异的初步分析

检测种质资源的多样性对于利用和有效管理种质非常重要。本研究对87份世界来源的扁穗雀麦种质利用常用的9个形态-农艺性状进行了统一田间评价。结果表明,所有采用的性状变异系数均表现出高度的变异,尤其以单株干物质产量、分蘖数和叶宽的变异幅度最大。反映株型大小的各性状之间呈显著相关,茎粗和第一节间长与其余8个性状之间存在显著相关(P<0.01),旗叶宽与倒二叶宽的正相关性最强(r=0.912,P<0.01)。主成分分析(PCA)表明前2个主成分可以解释总变异的74%。反映株型大小的性状以及分蘖数可能是扁穗雀麦种质形态变异的主要来源。基于欧氏距离的UPGMA聚类分析将供试材料分成3个主要的类群,第一类群具有最大的株型表现,茎干粗壮,旗叶和倒二叶宽大,分蘖数中等;第二类群具有中等的株型;第三类群具有较小的株型,叶片短而窄,但分蘖数较多。聚类分析很好地支持了前2个主成分分值的二维散点图的结果。总之,本研究表明扁穗雀麦是一种在西南平原和丘陵地区适应性极强的禾草,其表型多样性对于品种选育和资源收集具有重要的参考价值。     

雏鸡中枢免疫器官内B淋巴细胞变化规律

为了研究雏鸡在正常发育过程中免疫器官内B淋巴细胞的变化规律,以不同日龄的SPF鸡为研究对象,用流式细胞术检测鸡脾脏、胸腺及法氏囊内IgA+、IgG+及IgM+B淋巴细胞含量的变化情况。结果显示,在脾脏中,4日龄时B淋巴细胞含量比较多,7日龄时B淋巴细胞含量下降,随后,7至21日龄细胞含量逐渐升高;胸腺内则是在4日龄时IgM+B淋巴细胞含量相对较高,而IgA+、IgG+B淋巴细胞几乎没有;在法氏囊中,IgA+、IgG+及IgM+B淋巴细胞含量在4至14日龄时逐渐升高,并且IgA+和IgG+细胞含量在21日龄时基本趋于稳定,但是IgM+B细胞含量则在21日龄时有所下降。试验结果表明,雏鸡出壳后各免疫器官B淋巴细胞始终以IgM+细胞含量最多。     

温控条件下高温胁迫对紫花苜蓿地上部分生长的影响

本研究的目的在于探讨高温对紫花苜蓿(Medicago sativa)产量和形态的影响。试验采用盆栽方法,选取6个紫花苜蓿品种,将其种植在2个生长培养箱内,2个培养箱温度(白天/黑暗)分别设置为25/20℃和35/30℃,测定其产量、株高、叶部特征及叶片叶绿素含量。结果表明,高温胁迫使紫花苜蓿生长受到抑制,植株矮小,产量降低54%;单叶片叶面积缩小至常温的1/4,但叶片厚度增加了54%。综合上述结果可以看出,高温是生产中紫花苜蓿夏季减产的一个重要原因,紫花苜蓿对高温非常敏感,但会通过一系列形态上的变化来适应高温的胁迫。     

口蹄疫灭活疫苗蛋白质含量测定操作程序的确立

为优化用于口蹄疫灭活疫苗蛋白质含量测定的改良Lowry法,进而确立口蹄疫灭活疫苗蛋白质含量测定的操作程序,探索了有机溶剂破乳剂、酚红以及丙酮沉淀对测定结果影响。结果表明：样品中含酚红和有机溶剂均导致测定值较标准值高;有机溶剂破乳后,水相样经过丙酮沉淀测定值较标准值低;丙酮直接沉淀疫苗后测定蛋白质值与标准值符合度最高,丙酮沉淀回收率随蛋白浓度升高而升高,回收率在90％～100％之间。试验首次确立了改良Lowry法检测口蹄疫灭活疫苗中蛋白质含量的操作程序为丙酮直接沉淀疫苗后测定蛋白质浓度。并成功应用于口蹄疫灭活疫苗蛋白质含量的测定。     

Indices of renal function: reference values in normal horses

Urine and blood samples were taken at the same time from normal adult horses presented for routine investigations to establish reference values for a variety of parameters reported to be useful in the clinical evaluation of renal function. Blood biochemical values were consistent with previous studies and had well-defined normal ranges. Parameters representing urine concentration and electrolyte excretion however, varied widely reflecting the ability of the healthy kidney to change the composition of urine in response to differences in environment and management. Percent creatinine clearance ratios for potassium in particular were lower than those reported in normal horses in previous studies. Rational interpretation of these latter measurements should accept a wide range of normal values and management conditions must be considered in this interpretation.     

动物干扰素原核表达及其产物制备方法研究进展

文章对重组动物干扰素基因序列的改造、原核表达条件的筛选、原核表达产物制备方法的研究及大规模生产工艺的研发等方面的发展状况进行了概述,旨在为其大规模生产提供一定的理论依据。     

Thrombolytic Therapy in Dogs and Cats

Objective: To review the thrombolytic agents most commonly used in humans, their mechanisms of action, potential uses, adverse effects, and reports of their use in dogs and cats.
Human data synthesis: Thrombolytic agents avaliable in human medicine include streptokinase, urokinase, tissueplasminogen activator (t-PA), single-chain urokinase plasma activator (scu-PA) and anisoylated plasminogen-strep-tokinase activator complex (APSAC). These agents were originally used for the management of proximal deep vein thrombosis and severe pulmonary embolism but more recently, use of these drugs has been extended to include the treatment of acute peripheral arterial disease, cerebrovascular disease (stroke) and acute coronary thrombosis. The most predictable side effect associated with the use of thrombolytic therapy is hemorrhage.
Veterinary data synthesis: Clinical experience with thrombolytic agents in small animals is limited to streptokinase and t-PA. It is possible, that as in humans, canine and feline patients with PTE and right ventricular dysfunction may benefit from thrombolytic therapy but there are no veterinary studies to support this theory to date. Successful use of streptokinase has been documented in a small number of canine patients with systemic thromboembolism. ⁶³ Thrombolytic therapy is relatively efficacious in cats with aortic thromboemboli but is associated with a high mortality rate. ^59,60,64 With regard to use of t-PA in veterinary medicine, the small number of animals treated with varying protocols makes it impossible to provide safe and effective dose recommendations at this time.
Conclusions: Future goals for thrombolytic therapy in veterinary medicine include determination of more specific clinical indications, as well as design of effective protocols that minimize mortality and morbidity.